Also known as: NMRC
Namibian government regulator responsible for approving medicines and ensuring pharmaceutical products are safe, effective, and of high quality.
Key points drawn from coverage. Tap a point to see the original sentence.
The Namibian
NMRC will continue monitoring the safety of these products
“She added that the NMRC will continue its commitment to monitoring the safety of these products and will consider regulatory changes if necessary.”
Public urged to exercise caution with zinc picolinate and selenium in childrenThe Namibia Medicines Regulatory Council has cleared Fabupharm Pty Ltd's paracetamol syrup for use after independent laboratory tests confirmed it met safety and quality standards. The clearance was issued in May following the product's recall last year, which came after routine inspection shortcomings were identified.
24 June 2026 · The Namibian →
The Namibia Medicines Regulatory Council has cleared Fabupharm Pty Ltd's paracetamol syrup for use after independent laboratory tests confirmed it met safety and quality standards. The clearance was issued in May following the product's recall last year, which came after routine inspection shortcomings were identified.
24 June 2026 · The Namibian →
The Namibia Medicines Regulatory Council has confirmed that Fabu-Paracetamol meets required safety and quality standards following independent laboratory testing of samples from health facilities. The tests found all batches complied with quality specifications, contained correct active pharmaceutical ingredient levels, and contained no toxic contaminants such as diethylene glycol or ethylene glycol.
24 June 2026 · Windhoek Observer →
The Ministry of Health and Social Services has cancelled pharmaceutical and clinical product orders worth N$44.8 million extended to 12 companies after suppliers failed to deliver medicines to the Central Medical Stores, including treatments for mental illness, cancer, and chronic conditions.
15 June 2026 · The Namibian →
The Anti-Corruption Commission has issued a formal summons to a member of the ministry of health and social services' Bid Evaluation Committee to appear for questioning over allegations of procurement manipulation, supply chain fraud, and theft of pharmaceutical medicines from state warehouses. The official is to appear before an ACC investigator on 18 August 2026.
9 June 2026 · Windhoek Observer →
The Ministry of Health and Social Services has removed Fransina Nambahu as registrar of medicines at the Namibia Medicines Regulatory Council and appointed Frieda Shiweda to the position effective 1 June 2026. Sources told the Windhoek Observer that Nambahu was removed after refusing to approve substandard medicines, contradicting the ministry's stated reason of structural review.
1 June 2026 · Windhoek Observer →
President Netumbo Nandi-Ndaitwah said medicine shortages in public hospitals are a major burden on her administration, after the Ministry of Health and Social Services revealed national pharmaceutical stock levels are at 60%, below the government's 80% minimum target.
21 May 2026 · Windhoek Observer →
Namibia is strengthening its medicine safety systems as African countries push for closer regulatory cooperation through the African Medicines Agency to address concerns over counterfeit medicines and weak reporting systems for medicine side effects. The Ministry of Health and Social Services says stronger cooperation between African regulators would help countries respond faster to harmful medicines, improve monitoring of side effects and reduce dependence on foreign regulatory systems.
20 May 2026 · Windhoek Observer →
The Ministry of Health and Social Services has intensified efforts to stabilise Namibia's pharmaceutical supply chain, with essential medicines and clinical supplies delivered to the Central Medical Stores over the past two weeks. The country's pharmaceutical stock service level currently stands at about 60%, below the targeted minimum of 80%, though urgent procurement interventions are showing progress.
19 May 2026 · New Era →
The Ministry of Health reports that several essential pharmaceutical products are in short supply or out of stock at health facilities. The Central Medical Stores received pharmaceutical and clinical supplies between 27 April and 15 May 2026, including stocks of seizure control medication, blood glucose test strips, and blood pressure management drugs, intended to address urgent needs and stabilise inventory levels.
18 May 2026 · Informanté →
The Asoli Progressive Party has criticized President Netumbo Nandi-Ndaitwah for what it describes as insufficient response to ongoing medicine shortages in public hospitals, with the party's president Josef Kauandenge saying the government has not acted with enough urgency. Public concern has grown in recent weeks after patients were referred to private pharmacies due to stock-outs, though the Ministry of Health and Social Services announced it will now provide monthly updates on pharmaceutical supplies, with current stock levels at about 60% of required quantities.
18 May 2026 · Windhoek Observer →
Following a South African recall of Citro-Soda antacid batches, Namibia's Health Ministry is investigating whether affected products entered the local market and will consult with the Medicines Regulatory Council. The ministry has advised the public to remain vigilant and consult healthcare professionals if they experience unusual symptoms after using the product.
23 March 2026 · The Namibian →
The Minister of Health and Social Services has officially appointed new members to the Namibia Medicines Regulatory Council, tasking them with regulating medicines and related substances to ensure products reaching the public are safe, effective, and of high quality. The minister warned against attempts to compromise the Council's integrity through corruption or favouritism.
14 March 2026 · Informanté →
Health Minister Dr Esperance Luvindao has instructed newly appointed members of the Namibia Medicines Regulatory Council to declare any commercial interests in the pharmaceutical or healthcare industry within three months, emphasising transparency and conflict-of-interest prevention. Failure to disclose conflicts can render council proceedings invalid or result in criminal penalties of up to N$8,000 in fines or two years' imprisonment.
13 March 2026 · New Era →
Namibia's Medicines Regulatory Council has advised consumers to consult healthcare professionals before using zinc picolinate and selenium-containing supplements, particularly for children under 18. The council urged the public to report any suspected adverse events to the Therapeutic Information and Pharmacovigilance Centre.
27 January 2026 · New Era →
Namibia's Medicines Regulatory Council has urged the public to consult healthcare professionals before using supplements containing zinc picolinate and selenium, especially for children under 18, following safety concerns from South Africa's health regulator. The NMRC is not recalling the products but says consumers should seek professional advice, and has urged reporting of any adverse effects.
21 January 2026 · Informanté →
The Namibia Medicines Regulatory Council has advised the public and healthcare professionals to exercise caution when using products containing zinc picolinate and selenium in children under 18, following South Africa's recall of similar products. While no Namibian recall has been mandated, the NMRC emphasises consulting healthcare professionals before giving these supplements to children and encourages reporting of adverse reactions.
19 January 2026 · The Namibian →